-2%
Terbinafine + Itraconazole combination therapy provides superior clinical outcomes compared to monotherapy for fungal skin diseases. This regimen results in:
- Faster symptom resolution
- Higher cure rates
- Excellent safety profile
- Greater patient satisfaction
Clinical Efficacy of Terbinafine + Itraconazole Combination Therapy in Fungal Skin Infections: Enhanced Outcomes through Synergistic Antifungal Action
Terbinafine and Itraconazole are widely prescribed antifungal agents in clinical settings. In vitro research has demonstrated that their combination delivers superior antifungal activity. However, clinical evidence supporting this synergy remained limited until recently.
To evaluate the therapeutic efficacy of combined Terbinafine + Itraconazole therapy compared to monotherapy in the treatment of fungal skin infections.